 | • レポートコード：GIR201104554 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、線維筋痛症治療の世界市場を調査対象にし、線維筋痛症治療の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（抗うつ薬、抗けいれん薬、筋弛緩薬、麻薬性鎮痛薬、非麻薬性鎮痛薬）、用途別分析（病院薬局、クリニック薬局、小売ドラッグストア、オンライン薬局）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Eli Lilly and Company、Intec Pharma Ltd.、Allergan、Pfizer、Innovative Med Concepts、Novartis AG、Savella、Prismic Pharmaceuticals、Aptinyx、Astellas Pharma、Forest Pharmaceuticals、Theravance Biopharma、Sun Pharmaceutical Industries、Meiji Seika Pharma、Daiichi Sankyo、Mylan NV、Tonix Pharmaceuticals、Teva Pharmaceutical Industries ・メーカー別販売量、売上、市場シェア ・線維筋痛症治療の地域別市場分析 ・線維筋痛症治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・線維筋痛症治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・線維筋痛症治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・線維筋痛症治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・線維筋痛症治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・線維筋痛症治療の種類別市場規模2015-2020：抗うつ薬、抗けいれん薬、筋弛緩薬、麻薬性鎮痛薬、非麻薬性鎮痛薬 ・線維筋痛症治療の用途別市場規模2015-2020：病院薬局、クリニック薬局、小売ドラッグストア、オンライン薬局 ・線維筋痛症治療の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Fibromyalgia Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Fibromyalgia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Fibromyalgia Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Fibromyalgia Treatment market has been segmented into
Antidepressants
Anticonvulsants
Muscle Relaxants
Narcotic Analgesics
Non-narcotic Analgesics
By Application, Fibromyalgia Treatment has been segmented into:
Hospitals Pharmacies
Clinic Pharmacy
Retail Drug Stores
Online Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Fibromyalgia Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Fibromyalgia Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Fibromyalgia Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Fibromyalgia Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Fibromyalgia Treatment Market Share Analysis
Fibromyalgia Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Fibromyalgia Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Fibromyalgia Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Fibromyalgia Treatment are:
Eli Lilly and Company
Intec Pharma Ltd.
Allergan
Pfizer
Innovative Med Concepts
Novartis AG
Savella
Prismic Pharmaceuticals
Aptinyx
Astellas Pharma
Forest Pharmaceuticals
Theravance Biopharma
Sun Pharmaceutical Industries
Meiji Seika Pharma
Daiichi Sankyo
Mylan NV
Tonix Pharmaceuticals
Teva Pharmaceutical Industries
Among other players domestic and global, Fibromyalgia Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fibromyalgia Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Fibromyalgia Treatment, with price, sales, revenue and global market share of Fibromyalgia Treatment in 2018 and 2019.
Chapter 3, the Fibromyalgia Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fibromyalgia Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Fibromyalgia Treatment market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Fibromyalgia Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Fibromyalgia Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Fibromyalgia Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Antidepressants
1.2.3 Anticonvulsants
1.2.4 Muscle Relaxants
1.2.5 Narcotic Analgesics
1.2.6 Non-narcotic Analgesics
1.3 Market Analysis by Application
1.3.1 Overview: Global Fibromyalgia Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals Pharmacies
1.3.3 Clinic Pharmacy
1.3.4 Retail Drug Stores
1.3.5 Online Pharmacies
1.4 Overview of Global Fibromyalgia Treatment Market
1.4.1 Global Fibromyalgia Treatment Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly and Company
2.1.1 Eli Lilly and Company Details
2.1.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eli Lilly and Company SWOT Analysis
2.1.4 Eli Lilly and Company Product and Services
2.1.5 Eli Lilly and Company Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Intec Pharma Ltd.
2.2.1 Intec Pharma Ltd. Details
2.2.2 Intec Pharma Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Intec Pharma Ltd. SWOT Analysis
2.2.4 Intec Pharma Ltd. Product and Services
2.2.5 Intec Pharma Ltd. Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Allergan
2.3.1 Allergan Details
2.3.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Allergan SWOT Analysis
2.3.4 Allergan Product and Services
2.3.5 Allergan Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Innovative Med Concepts
2.5.1 Innovative Med Concepts Details
2.5.2 Innovative Med Concepts Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Innovative Med Concepts SWOT Analysis
2.5.4 Innovative Med Concepts Product and Services
2.5.5 Innovative Med Concepts Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis AG
2.6.1 Novartis AG Details
2.6.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis AG SWOT Analysis
2.6.4 Novartis AG Product and Services
2.6.5 Novartis AG Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Savella
2.7.1 Savella Details
2.7.2 Savella Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Savella SWOT Analysis
2.7.4 Savella Product and Services
2.7.5 Savella Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Prismic Pharmaceuticals
2.8.1 Prismic Pharmaceuticals Details
2.8.2 Prismic Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Prismic Pharmaceuticals SWOT Analysis
2.8.4 Prismic Pharmaceuticals Product and Services
2.8.5 Prismic Pharmaceuticals Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Aptinyx
2.9.1 Aptinyx Details
2.9.2 Aptinyx Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Aptinyx SWOT Analysis
2.9.4 Aptinyx Product and Services
2.9.5 Aptinyx Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Astellas Pharma
2.10.1 Astellas Pharma Details
2.10.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Astellas Pharma SWOT Analysis
2.10.4 Astellas Pharma Product and Services
2.10.5 Astellas Pharma Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Forest Pharmaceuticals
2.11.1 Forest Pharmaceuticals Details
2.11.2 Forest Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Forest Pharmaceuticals SWOT Analysis
2.11.4 Forest Pharmaceuticals Product and Services
2.11.5 Forest Pharmaceuticals Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Theravance Biopharma
2.12.1 Theravance Biopharma Details
2.12.2 Theravance Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Theravance Biopharma SWOT Analysis
2.12.4 Theravance Biopharma Product and Services
2.12.5 Theravance Biopharma Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Sun Pharmaceutical Industries
2.13.1 Sun Pharmaceutical Industries Details
2.13.2 Sun Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Sun Pharmaceutical Industries SWOT Analysis
2.13.4 Sun Pharmaceutical Industries Product and Services
2.13.5 Sun Pharmaceutical Industries Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Meiji Seika Pharma
2.14.1 Meiji Seika Pharma Details
2.14.2 Meiji Seika Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Meiji Seika Pharma SWOT Analysis
2.14.4 Meiji Seika Pharma Product and Services
2.14.5 Meiji Seika Pharma Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Daiichi Sankyo
2.15.1 Daiichi Sankyo Details
2.15.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Daiichi Sankyo SWOT Analysis
2.15.4 Daiichi Sankyo Product and Services
2.15.5 Daiichi Sankyo Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Mylan NV
2.16.1 Mylan NV Details
2.16.2 Mylan NV Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Mylan NV SWOT Analysis
2.16.4 Mylan NV Product and Services
2.16.5 Mylan NV Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Tonix Pharmaceuticals
2.17.1 Tonix Pharmaceuticals Details
2.17.2 Tonix Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Tonix Pharmaceuticals SWOT Analysis
2.17.4 Tonix Pharmaceuticals Product and Services
2.17.5 Tonix Pharmaceuticals Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Teva Pharmaceutical Industries
2.18.1 Teva Pharmaceutical Industries Details
2.18.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Teva Pharmaceutical Industries SWOT Analysis
2.18.4 Teva Pharmaceutical Industries Product and Services
2.18.5 Teva Pharmaceutical Industries Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Fibromyalgia Treatment Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Fibromyalgia Treatment Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Fibromyalgia Treatment Manufacturer Market Share in 2019
3.3.2 Top 6 Fibromyalgia Treatment Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Fibromyalgia Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Fibromyalgia Treatment Sales and Market Share by Regions (2015-2020)
4.1.2 Global Fibromyalgia Treatment Revenue and Market Share by Regions (2015-2020)
4.2 North America Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
4.3 Europe Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
4.5 South America Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Fibromyalgia Treatment Sales, Revenue and Market Share by Country
5.1.1 North America Fibromyalgia Treatment Sales and Market Share by Country (2015-2020)
5.1.2 North America Fibromyalgia Treatment Revenue and Market Share by Country (2015-2020)
5.2 United States Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
5.3 Canada Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
5.4 Mexico Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Fibromyalgia Treatment Sales, Revenue and Market Share by Country
6.1.1 Europe Fibromyalgia Treatment Sales and Market Share by Country (2015-2020)
6.1.2 Europe Fibromyalgia Treatment Revenue and Market Share by Country (2015-2020)
6.2 Germany Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
6.3 UK Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
6.4 France Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
6.5 Russia Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
6.6 Italy Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Fibromyalgia Treatment Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Fibromyalgia Treatment Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Fibromyalgia Treatment Revenue and Market Share by Regions (2015-2020)
7.2 China Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
7.3 Japan Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
7.4 Korea Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
7.5 India Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
7.7 Australia Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Fibromyalgia Treatment Sales, Revenue and Market Share by Country
8.1.1 South America Fibromyalgia Treatment Sales and Market Share by Country (2015-2020)
8.1.2 South America Fibromyalgia Treatment Revenue and Market Share by Country (2015-2020)
8.2 Brazil Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
8.3 Argentina Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Fibromyalgia Treatment Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Fibromyalgia Treatment Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Fibromyalgia Treatment Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
9.3 Turkey Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
9.4 Egypt Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
9.5 South Africa Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Fibromyalgia Treatment Sales and Market Share by Type (2015-2020)
10.2 Global Fibromyalgia Treatment Revenue and Market Share by Type (2015-2020)
10.3 Global Fibromyalgia Treatment Price by Type (2015-2020)
11 Global Fibromyalgia Treatment Market Segment by Application
11.1 Global Fibromyalgia Treatment Sales Market Share by Application (2015-2020)
11.2 Global Fibromyalgia Treatment Revenue Market Share by Application (2015-2020)
11.3 Global Fibromyalgia Treatment Price by Application (2015-2020)
12 Market Forecast
12.1 Global Fibromyalgia Treatment Sales, Revenue and Growth Rate (2021-2025)
12.2 Fibromyalgia Treatment Market Forecast by Regions (2021-2025)
12.2.1 North America Fibromyalgia Treatment Market Forecast (2021-2025)
12.2.2 Europe Fibromyalgia Treatment Market Forecast (2021-2025)
12.2.3 Asia-Pacific Fibromyalgia Treatment Market Forecast (2021-2025)
12.2.4 South America Fibromyalgia Treatment Market Forecast (2021-2025)
12.2.5 Middle East & Africa Fibromyalgia Treatment Market Forecast (2021-2025)
12.3 Fibromyalgia Treatment Market Forecast by Type (2021-2025)
12.3.1 Global Fibromyalgia Treatment Sales Forecast by Type (2021-2025)
12.3.2 Global Fibromyalgia Treatment Market Share Forecast by Type (2021-2025)
12.4 Fibromyalgia Treatment Market Forecast by Application (2021-2025)
12.4.1 Global Fibromyalgia Treatment Sales Forecast by Application (2021-2025)
12.4.2 Global Fibromyalgia Treatment Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Fibromyalgia Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Fibromyalgia Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Fibromyalgia Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly and Company Fibromyalgia Treatment Major Business
Table 9. Eli Lilly and Company Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 10. Eli Lilly and Company SWOT Analysis
Table 11. Eli Lilly and Company Fibromyalgia Treatment Product and Services
Table 12. Eli Lilly and Company Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Intec Pharma Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Intec Pharma Ltd. Fibromyalgia Treatment Major Business
Table 15. Intec Pharma Ltd. Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 16. Intec Pharma Ltd. SWOT Analysis
Table 17. Intec Pharma Ltd. Fibromyalgia Treatment Product and Services
Table 18. Intec Pharma Ltd. Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Allergan Basic Information, Manufacturing Base and Competitors
Table 20. Allergan Fibromyalgia Treatment Major Business
Table 21. Allergan Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 22. Allergan SWOT Analysis
Table 23. Allergan Fibromyalgia Treatment Product and Services
Table 24. Allergan Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Fibromyalgia Treatment Major Business
Table 27. Pfizer Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Fibromyalgia Treatment Product and Services
Table 30. Pfizer Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Innovative Med Concepts Basic Information, Manufacturing Base and Competitors
Table 32. Innovative Med Concepts Fibromyalgia Treatment Major Business
Table 33. Innovative Med Concepts Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 34. Innovative Med Concepts SWOT Analysis
Table 35. Innovative Med Concepts Fibromyalgia Treatment Product and Services
Table 36. Innovative Med Concepts Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 38. Novartis AG Fibromyalgia Treatment Major Business
Table 39. Novartis AG Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 40. Novartis AG SWOT Analysis
Table 41. Novartis AG Fibromyalgia Treatment Product and Services
Table 42. Novartis AG Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Savella Basic Information, Manufacturing Base and Competitors
Table 44. Savella Fibromyalgia Treatment Major Business
Table 45. Savella Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 46. Savella SWOT Analysis
Table 47. Savella Fibromyalgia Treatment Product and Services
Table 48. Savella Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Prismic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 50. Prismic Pharmaceuticals Fibromyalgia Treatment Major Business
Table 51. Prismic Pharmaceuticals Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 52. Prismic Pharmaceuticals SWOT Analysis
Table 53. Prismic Pharmaceuticals Fibromyalgia Treatment Product and Services
Table 54. Prismic Pharmaceuticals Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Aptinyx Basic Information, Manufacturing Base and Competitors
Table 56. Aptinyx Fibromyalgia Treatment Major Business
Table 57. Aptinyx Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 58. Aptinyx SWOT Analysis
Table 59. Aptinyx Fibromyalgia Treatment Product and Services
Table 60. Aptinyx Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 62. Astellas Pharma Fibromyalgia Treatment Major Business
Table 63. Astellas Pharma Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 64. Astellas Pharma SWOT Analysis
Table 65. Astellas Pharma Fibromyalgia Treatment Product and Services
Table 66. Astellas Pharma Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Forest Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Forest Pharmaceuticals Fibromyalgia Treatment Major Business
Table 69. Forest Pharmaceuticals Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 70. Forest Pharmaceuticals SWOT Analysis
Table 71. Forest Pharmaceuticals Fibromyalgia Treatment Product and Services
Table 72. Forest Pharmaceuticals Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Theravance Biopharma Basic Information, Manufacturing Base and Competitors
Table 74. Theravance Biopharma Fibromyalgia Treatment Major Business
Table 75. Theravance Biopharma Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 76. Theravance Biopharma SWOT Analysis
Table 77. Theravance Biopharma Fibromyalgia Treatment Product and Services
Table 78. Theravance Biopharma Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 80. Sun Pharmaceutical Industries Fibromyalgia Treatment Major Business
Table 81. Sun Pharmaceutical Industries Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 82. Sun Pharmaceutical Industries SWOT Analysis
Table 83. Sun Pharmaceutical Industries Fibromyalgia Treatment Product and Services
Table 84. Sun Pharmaceutical Industries Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Meiji Seika Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Meiji Seika Pharma Fibromyalgia Treatment Major Business
Table 87. Meiji Seika Pharma Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 88. Meiji Seika Pharma SWOT Analysis
Table 89. Meiji Seika Pharma Fibromyalgia Treatment Product and Services
Table 90. Meiji Seika Pharma Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 92. Daiichi Sankyo Fibromyalgia Treatment Major Business
Table 93. Daiichi Sankyo Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 94. Daiichi Sankyo SWOT Analysis
Table 95. Daiichi Sankyo Fibromyalgia Treatment Product and Services
Table 96. Daiichi Sankyo Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Mylan NV Basic Information, Manufacturing Base and Competitors
Table 98. Mylan NV Fibromyalgia Treatment Major Business
Table 99. Mylan NV Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 100. Mylan NV SWOT Analysis
Table 101. Mylan NV Fibromyalgia Treatment Product and Services
Table 102. Mylan NV Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Tonix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 104. Tonix Pharmaceuticals Fibromyalgia Treatment Major Business
Table 105. Tonix Pharmaceuticals Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 106. Tonix Pharmaceuticals SWOT Analysis
Table 107. Tonix Pharmaceuticals Fibromyalgia Treatment Product and Services
Table 108. Tonix Pharmaceuticals Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Teva Pharmaceutical Industries Fibromyalgia Treatment Type and Application
Table 110. Teva Pharmaceutical Industries Fibromyalgia Treatment Major Business
Table 111. Teva Pharmaceutical Industries Fibromyalgia Treatment Total Revenue (USD Million) (2017-2018)
Table 112. Teva Pharmaceutical Industries SWOT Analysis
Table 113. Teva Pharmaceutical Industries Fibromyalgia Treatment Product and Services
Table 114. Teva Pharmaceutical Industries Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Global Fibromyalgia Treatment Sales by Manufacturer (2018-2019) (KG)
Table 116. Global Fibromyalgia Treatment Revenue by Manufacturer (2018-2019) (USD Million)
Table 117. Global Fibromyalgia Treatment Sales by Regions (2015-2020) (KG)
Table 118. Global Fibromyalgia Treatment Sales Market Share by Regions (2015-2020)
Table 119. Global Fibromyalgia Treatment Revenue by Regions (2015-2020) (USD Million)
Table 120. North America Fibromyalgia Treatment Sales by Countries (2015-2020) (KG)
Table 121. North America Fibromyalgia Treatment Sales Market Share by Countries (2015-2020)
Table 122. North America Fibromyalgia Treatment Revenue by Countries (2015-2020) (USD Million)
Table 123. North America Fibromyalgia Treatment Revenue Market Share by Countries (2015-2020)
Table 124. Europe Fibromyalgia Treatment Sales by Countries (2015-2020) (KG)
Table 125. Europe Fibromyalgia Treatment Sales Market Share by Countries (2015-2020)
Table 126. Europe Fibromyalgia Treatment Revenue by Countries (2015-2020) (USD Million)
Table 127. Asia-Pacific Fibromyalgia Treatment Sales by Regions (2015-2020) (KG)
Table 128. Asia-Pacific Fibromyalgia Treatment Sales Market Share by Regions (2015-2020)
Table 129. Asia-Pacific Fibromyalgia Treatment Revenue by Regions (2015-2020) (USD Million)
Table 130. South America Fibromyalgia Treatment Sales by Countries (2015-2020) (KG)
Table 131. South America Fibromyalgia Treatment Sales Market Share by Countries (2015-2020)
Table 132. South America Fibromyalgia Treatment Revenue by Countries (2015-2020) (USD Million)
Table 133. South America Fibromyalgia Treatment Revenue Market Share by Countries (2015-2020)
Table 134. Middle East & Africa Fibromyalgia Treatment Sales by Countries (2015-2020) (KG)
Table 135. Middle East & Africa Fibromyalgia Treatment Sales Market Share by Countries (2015-2020)
Table 136. Middle East & Africa Fibromyalgia Treatment Revenue by Countries (2015-2020) (USD Million)
Table 137. Middle East & Africa Fibromyalgia Treatment Revenue Market Share by Countries (2015-2020)
Table 138. Global Fibromyalgia Treatment Sales by Type (2015-2020) (KG)
Table 139. Global Fibromyalgia Treatment Sales Share by Type (2015-2020)
Table 140. Global Fibromyalgia Treatment Revenue by Type (2015-2020) (USD Million)
Table 141. Global Fibromyalgia Treatment Revenue Share by Type (2015-2020)
Table 142. Global Fibromyalgia Treatment Sales by Application (2015-2020) (KG)
Table 143. Global Fibromyalgia Treatment Sales Share by Application (2015-2020)
Table 144. Global Fibromyalgia Treatment Sales Forecast by Regions (2021-2025) (KG)
Table 145. Global Fibromyalgia Treatment Market Share Forecast by Regions (2021-2025)
Table 146. Global Fibromyalgia Treatment Sales Forecast by Type (2021-2025) (KG)
Table 147. Global Fibromyalgia Treatment Market Share Forecast by Type (2021-2025)
Table 148. Global Fibromyalgia Treatment Sales Forecast by Application (2021-2025)
Table 149. Global Fibromyalgia Treatment Market Share Forecast by Application (2021-2025)
Table 150. Direct Channel Pros & Cons
Table 151. Indirect Channel Pros & Cons
Table 152. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Fibromyalgia Treatment Picture
Figure 2. Global Sales Market Share of Fibromyalgia Treatment by Type in 2019
Figure 3. Antidepressants Picture
Figure 4. Anticonvulsants Picture
Figure 5. Muscle Relaxants Picture
Figure 6. Narcotic Analgesics Picture
Figure 7. Non-narcotic Analgesics Picture
Figure 8. Fibromyalgia Treatment Sales Market Share by Application in 2018
Figure 9. Hospitals Pharmacies Picture
Figure 10. Clinic Pharmacy Picture
Figure 11. Retail Drug Stores Picture
Figure 12. Online Pharmacies Picture
Figure 13. Global Fibromyalgia Treatment Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Fibromyalgia Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Fibromyalgia Treatment Sales Market Share by Manufacturer in 2019
Figure 34. Global Fibromyalgia Treatment Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Fibromyalgia Treatment Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Fibromyalgia Treatment Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 39. Global Fibromyalgia Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Fibromyalgia Treatment Revenue Market Share by Regions (2015-2020)
Figure 41. Global Fibromyalgia Treatment Revenue Market Share by Regions in 2018
Figure 42. North America Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
Figure 43. Europe Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
Figure 45. South America Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Fibromyalgia Treatment Sales and Growth Rate (2015-2020)
Figure 47. North America Fibromyalgia Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Fibromyalgia Treatment Sales Market Share by Countries (2015-2020)
Figure 49. North America Fibromyalgia Treatment Sales Market Share by Countries in 2018
Figure 50. North America Fibromyalgia Treatment Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Fibromyalgia Treatment Revenue Market Share by Countries in 2018
Figure 52. United States Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 53. Canada Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 54. Mexico Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 55. Europe Fibromyalgia Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Fibromyalgia Treatment Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Fibromyalgia Treatment Revenue Market Share by Countries in 2019
Figure 58. Germany Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 59. UK Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 60. France Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 61. Russia Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 62. Italy Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 63. Asia-Pacific Fibromyalgia Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Fibromyalgia Treatment Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Fibromyalgia Treatment Revenue Market Share by Regions 2019
Figure 66. China Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 67. Japan Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 68. Korea Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 69. India Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 70. Southeast Asia Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 71. South America Fibromyalgia Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Fibromyalgia Treatment Sales Market Share by Countries in 2019
Figure 73. South America Fibromyalgia Treatment Revenue Market Share by Countries in 2019
Figure 74. Brazil Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 75. Argentina Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 76. Middle East and Africa Fibromyalgia Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Fibromyalgia Treatment Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Fibromyalgia Treatment Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Fibromyalgia Treatment Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 81. Egypt Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 82. Turkey Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 83. South Africa Fibromyalgia Treatment Sales and Growth Rate (2015-2020) (KG)
Figure 84. Global Fibromyalgia Treatment Sales and Growth Rate (2021-2025) (KG)
Figure 85. Global Fibromyalgia Treatment Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Fibromyalgia Treatment Market Forecast (2021-2025) (KG)
Figure 87. Europe Sales Fibromyalgia Treatment Market Forecast (2021-2025) (KG)
Figure 88. Asia-Pacific Sales Fibromyalgia Treatment Market Forecast (2021-2025) (KG)
Figure 89. South America Sales Fibromyalgia Treatment Market Forecast (2021-2025) (KG)
Figure 90. Middle East & Africa Sales Fibromyalgia Treatment Market Forecast (2021-2025) (KG)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
線維筋痛症治療薬の世界市場 2020年 Market Overview The global Fibromyalgia Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Fibromyalgia Drugs market …- 酒さ治療の世界市場 2020年 Market Overview The global Rosacea Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 1721.7 million by 2025, from USD 1526 million in 2019. The Rosacea Treatment ma…
- 心的外傷後ストレス障害治療の世界市場 2020年 Market Overview The global Post-Traumatic Stress Disorder Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Post…
- 皮膚線維腫治療の世界市場 2020年 Market Overview The global Treatment of Skin Fibrosis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Treatment of Skin …
- 軟骨無形成症治療の世界市場 2020年 Market Overview The global Achondroplasia Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Achondroplasia Treat…